Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Won Sang Eun¹,Park Hyo Jung¹,Byun Sangil¹,Pyo Junhee²,Kim Jwa Hoon³,Choi Chang-Min³,Lee Jae Cheol³,Lee Dae Ho³,Kim Sang-We³,Yoon Shinkyo³,Kim Kyung Won¹

Affiliation:

1. Department of Radiology and Research Institute of Radiology, Asan Image Metrics, Asan Medical Center, Seoul, Republic of Korea

2. WHO Collaborating Center for Pharmaceutical Policy and Regulation, Department of Pharmaceutical Science, Utrecht University, Utrecht, The Netherlands

3. Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea

Funder

by a grant from the National R&D Program for Cancer Control

National Research Foundation of Korea

National R&D Program for Cancer Control, Ministry of Health & Welfare of Korea

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1776058

Reference32 articles.

1. The blockade of immune checkpoints in cancer immunotherapy

2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

3. National Comprehensive Cancer Network. Non-small cell lung cancer version 7.2019 [accessed 2019 Jan 01]. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

4. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

5. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning in radiology for lung cancer diagnostics: A systematic review of classification, segmentation, and predictive modeling techniques;Expert Systems with Applications;2024-12

2. The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach;Frontiers in Immunology;2024-09-09

3. Repeated dynamic [18F]FDG PET/CT imaging using a high-sensitivity PET/CT scanner for assessing non-small cell lung cancer patients undergoing induction immuno-chemotherapy followed by hypo-fractionated chemoradiotherapy and consolidative immunotherapy: report from a prospective observational study (GASTO-1067);European Journal of Nuclear Medicine and Molecular Imaging;2024-07-02

4. Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma;European Urology Focus;2024-06

5. Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma;European Journal of Immunology;2023-12-08